Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$115,680,773
+$21,533,152 QoQ
Shares Held
2,126,094
-3.1% QoQ
Ownership
0.858%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. EXEL ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,680,773 | 2,126,094 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $94,147,621 | 2,195,095 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $95,478,172 | 2,178,375 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $94,216,737 | 2,281,277 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $101,969,072 | 2,313,273 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $87,534,437 | 2,370,922 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $82,532,716 | 2,478,460 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $51,171,348 | 1,971,921 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $47,016,540 | 2,092,414 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $45,061,892 | 1,898,942 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $53,229,802 | 2,218,833 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $49,585,820 | 2,269,374 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $44,409,842 | 2,323,906 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $48,218,980 | 2,484,234 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,069,701 | 2,435,767 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $38,035,335 | 2,425,723 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $50,866,423 | 2,443,152 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $56,047,447 | 2,472,318 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $46,221,179 | 2,528,511 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $54,270,055 | 2,567,174 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $47,420,536 | 2,602,664 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $59,106,032 | 2,616,469 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $48,318,842 | 2,407,516 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $59,055,989 | 2,415,378 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $59,262,871 | 2,496,330 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $42,238,403 | 2,452,869 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||